SESSION 1: IMPROVING QUALITY of LIFE PANEL 1.1B: Human health - - PowerPoint PPT Presentation

session 1 improving quality of life panel 1 1b human
SMART_READER_LITE
LIVE PREVIEW

SESSION 1: IMPROVING QUALITY of LIFE PANEL 1.1B: Human health - - PowerPoint PPT Presentation

SESSION 1: IMPROVING QUALITY of LIFE PANEL 1.1B: Human health Research Director, Basic Research Division, CEA Sylvie Chevillard heads the Experimental Cancerology Laboratory and Department of Experimental Radiobiology and Innovative


slide-1
SLIDE 1

PANEL 1.1B: Human health SESSION 1: IMPROVING QUALITY of LIFE

Research Director, Basic Research Division, CEA Sylvie Chevillard heads the Experimental Cancerology Laboratory and Department

  • f Experimental Radiobiology and

Innovative Technology at the French National Institute of Health and Medical Research

Sylvie CHEVILLARD France

slide-2
SLIDE 2

METALLIC NANOPARTICLES: PROMISING TOOLS TO ENHANCE EFFICACY AND DOSIMETRY IN RADIOTHERAPY

BASIC RESEARCH DEPARTMENT INSTITUT OF BIOLOGY FRANÇOIS JACOB CANCEROLOGY EXPERIMENTAL UNIT

Sylvie Chevillard

| PAGE 2 CEA | 10 AVRIL 2012

slide-3
SLIDE 3

6 DÉCEMBRE 2018

Radiotherapy

Radiotherapy a major treatment for cancer

  • 50% of cancer patients received RX
  • 20% of cancer are radiation-resistant

Radiotherapy road map improvements

  • better target the tumor
  • total dose split
  • higher dose per session
  • higher dose rate

Main challenges

  • increase radiation efficacy, while preserving healthy tissues
  • vercome resistance and/or tumor relapse?
  • intratumoral radiation dosimetry rather than calculation of the delivered radiation dose
  • is the dose currently delivered to the tumor the expected one? …
  • prevent accident during the time course of radiotherapy

53519 23279 14234 14665 41796 67951 10000 20000 30000 40000 50000 60000 70000 80000 Breast Prostate Lung VADS Metastasis Other

Patients

Patients treated by radiotherapy

n > 210 000

National Institute of Cancer (France) 2017

slide-4
SLIDE 4

Transversal skills and technical innovations in astrophysics, biology and chemistry

Metallic nanoparticles for radiotherapy enhancement and intratumoral radiation dosimetry

é é é é à ç

slide-5
SLIDE 5

6 DÉCEMBRE 2018

Indirect effects

ROS

Direct effects

Living cancer cells Dead cells Dead cells and living resistant cells

Sensitive tumor Resistant tumor

H2O

°OH + e-

Principle effects of radiotherapy on cancer cells

slide-6
SLIDE 6

Flurorescent emission Campton scattering Auger electrons Pair production positron & electron Electromagnetic scattering

High z metal

e- e+ e- e-

Direct effects

Additive indirect effects

ROS ROS

ROS

Indirect effects

Living cancer cells Dead cells

Sensitive and Resistant tumor

Nanoparticles : enhancement of radiotherapy

slide-7
SLIDE 7

Nanoparticles internalisation

MDAMB231 0µg/mL MDAMB231 50µg/mL 50µm

0.1 1 10 100 1000 10000 10 20 30 40 50

Number of cells

Millions Days

Irradiation + AuNP

10 20 30 40 50 60 8 20 28 40 47

Mortality (%)

irradiation

Cancer cells

Control 10µg/mL 50µg/mL

Nanoparticles enhancement of radiotherapy

DarkField microscopy

slide-8
SLIDE 8

6 DÉCEMBRE 2018

Flurorescent emission Campton scattering Auger electrons Pair production positron & electron Electromagnetic scattering

High z metal

e- e+ e- e-

Strictly proportional to the dose Photon detector

Nanoparticles : intratumoral radiation dosimetry

slide-9
SLIDE 9

Fluorescence detection of irradiated nanoparticles intratumoral radiotherapy dosimetry

6 DÉCEMBRE 2018 | PAGE 9

Sensitivity : 50 µg

slide-10
SLIDE 10

Conclusions

Main results

  • Improve efficacy of radiotherapy by killing resistant cancer cells – Better cure
  • Real time measurement of radiation dose delivered into the tumor – Better cure and increased

safety First attempts of XRF tomographic reconstruction for adjustment of NP exposure

6 DÉCEMBRE 2018

Combine transversal skills ans knowledge Disruptive technologies are only possible through multidisciplinary approaches

Still a lot of work to get to the patient, but all proofs of concept are there

slide-11
SLIDE 11

CEA DRF/IRFU Astrophysics Olivier Limousin, Diana Renaud, Daniel Maier, Franc̨ois Visticot, Pierre-Anne Bausson, Jêrõme Martignac CEA DRF/iRCM biology and cancer cells Sylvie Chevillard, Romain Grall, Jêrõme Lebeau, Jozo Delic, CEA DRT/LIST Robotics & tomography Hermine Lemaire, Caroline Vienne, Adrien Stolidi University Paris Sud / LCP Chemistry Cêcile Sicard, Emilie Brun, Stêphanie Droniou

Thank you for your attention